ArticleFrontiers in oncology2021

MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study.

Weihua Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.